Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Befimmo SA | BEFB | Apr 30, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Apr 30, 2024 | 3 883.26 | -0.09 |
Belreca - Belgian Resources and Capital Company | BELR | Apr 30, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 30, 2024 | 1.08 | -9.24 |
Belysse Group N.V. | BELYS | Apr 30, 2024 | 0.82 | 0.00 |
Biocartis Group NV | BCART | Apr 30, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 30, 2024 | 0.01 | -5.13 |
Biotalys | BTLS | Apr 30, 2024 | 3.10 | +1.97 |
Boeing | BOEI | Apr 30, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 30, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 30, 2024 | 3.69 | -1.73 |
Brederode S.A. | BREB | Apr 30, 2024 | 112.60 | -0.53 |
Campine nv | CAMB | Apr 30, 2024 | 75.00 | 0.00 |
Candela Invest | CAND | Apr 30, 2024 | 2.04 | -29.66 |
Care Property Invest NV/SA | CPINV | Apr 30, 2024 | 13.94 | +3.87 |
Celyad Oncology SA | CYAD | Apr 30, 2024 | 0.33 | -1.52 |
Cenergy Holdings | CENER | Apr 30, 2024 | 8.05 | +2.68 |
Chevron | CHTEX | Apr 30, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Apr 30, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Apr 30, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Apr 30, 2024 | 62.30 | -1.58 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Apr 30, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 30, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 30, 2024 | 43.42 | -0.60 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 30, 2024 | 262.00 | +1.16 |
Compagnie d`Entreprises CFE SA | CFEB | Apr 30, 2024 | 7.65 | +0.53 |
Connect Group | CONN | Apr 30, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Apr 30, 2024 | 0.01 | +1.54 |
Cumulex NV | CLEX | Apr 30, 2024 | 1.15 | 0.00 |
CURETIS | CURE | Apr 30, 2024 | 0.29 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.